These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18638711)

  • 1. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients.
    He Y; Lu A; Zha Y; Tsang I
    Complement Ther Med; 2008 Aug; 16(4):206-11. PubMed ID: 18638711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine.
    He Y; Lu A; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Lu C
    J Clin Rheumatol; 2007 Dec; 13(6):317-21. PubMed ID: 18176139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between tongue appearance in Traditional Chinese Medicine and effective response in treatment of rheumatoid arthritis.
    Jiang M; Zha Q; Lu C; He Y; Lu A
    Complement Ther Med; 2011 Jun; 19(3):115-21. PubMed ID: 21641515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine].
    He YT; Zha QL; Yu JP; Tan Y; Lu C; Lu AP
    Zhong Xi Yi Jie He Xue Bao; 2008 Jan; 6(1):32-6. PubMed ID: 18184543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stage-based treatment of gouty arthritis by combination therapy of traditional Chinese and Western medicines: a randomized controlled trial].
    Wang YF; Li BH; Zhang M; Xu WB; Zhou R; Zhou M
    Zhong Xi Yi Jie He Xue Bao; 2008 Jun; 6(6):576-80. PubMed ID: 18559233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive role of diagnostic information in treatment efficacy of rheumatoid arthritis based on neural network model analysis].
    Zha QL; He YT; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH; Lin SQ; Lü C; Lü AP
    Zhong Xi Yi Jie He Xue Bao; 2007 Jan; 5(1):32-8. PubMed ID: 17214933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on symptomatic factors of rheumatoid arthritis and its correlation with therapeutic efficacy].
    He YT; Zha QL; Yan XP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1077-81. PubMed ID: 16398426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations of clinical symptoms and treatment efficacy in patients with rheumatoid arthritis treated with Chinese herbal drugs or Western medicine].
    Lü AP; He YT; Zha QL; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH
    Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):432-7. PubMed ID: 16282050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis.
    Furst DE; Fleischmann R; Kopp E; Schiff M; Edwards C; Solinger A; Macri M;
    J Rheumatol; 2005 Dec; 32(12):2303-10. PubMed ID: 16331754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of the conventional drugs in the treatment of rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis.
    He Y; Lu A; Lu C; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Tsang I
    Am J Chin Med; 2008; 36(4):675-83. PubMed ID: 18711765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
    Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
    Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP
    Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.